Dilepton production in heavy ion collisions at intermediate energies

We present a unified description of the vector meson and dilepton production in elementary and in heavy ion reactions. The production of vector mesons ($\rho,\omega$) is described via the excitation of nuclear resonances ($R$). The theoretical framework is an extended vector meson dominance model (eVMD). The treatment of the resonance decays $R\longmapsto NV$ with arbitrary spin is covariant and kinematically complete. The eVMD includes thereby excited vector meson states in the transition form factors. This ensures correct asymptotics and provides a unified description of photonic and mesonic decays. The resonance model is successfully applied to the $\omega$ production in $p+p$ reactions. The same model is applied to the dilepton production in elementary reactions ($p+p, p+d$). Corresponding data are well reproduced. However, when the model is applied to heavy ion reactions in the BEVALAC/SIS energy range the experimental dilepton spectra measured by the DLS Collaboration are significantly underestimated at small invariant masses. As a possible solution of this problem the destruction of quantum interference in a dense medium is discussed. A decoherent emission through vector mesons decays enhances the corresponding dilepton yield in heavy ion reactions. In the vicinity of the $\rho/\omega$-peak the reproduction of the data requires further a substantial collisional broadening of the $\rho$ and in particular of the $\omega$ meson.Comment: 32 pages revtex, 19 figures, to appear in PR

ТКАНЕВАЯ И КЛЕТОЧНАЯ РЕАКЦИЯ СИНОВИАЛЬНОЙ СРЕДЫ НА ВНУТРИСУСТАВНОЕ ВВЕДЕНИЕ ПОЛИМЕРНОГО ВИСКОПРОТЕЗА «НОЛТРЕКС» В УСЛОВИЯХ ЭКСПЕРИМЕНТА

Reaction of synovial membrane and cartilage on 1 ml of polymer gel «NOLTREX» injected into the cavity of jumping joint of 20 rabbits was investigated. Biological inertness and safety of noltrex injected into the joint cavity was established.   Изучена реакция синовиальной оболочки и хряща 20 кроликов на введение 1 мл полимерного геля «Нолтрекс» в полость скакательного сустава. Сделан вывод о биологической инертности и безопасности нолтрекса при его введении в полость сустава

Functional Single-Chain Polymer Nanoparticles: Targeting and Imaging Pancreatic Tumors in Vivo

The development of tools for the early diagnosis of pancreatic adenocarcinoma is an urgent need in order to increase treatment success rate and reduce patient mortality. Here, we present a modular nanosystem platform integrating soft nanoparticles with a targeting peptide and an active imaging agent for diagnostics. Biocompatible single-chain polymer nanoparticles (SCPNs) based on poly(methacrylic acid) were prepared and functionalized with the somatostatin analogue PTR86 as the targeting moiety, since somatostatin receptors are overexpressed in pancreatic cancer. The gamma emitter 67Ga was incorporated by chelation and allowed in vivo investigation of the pharmacokinetic properties of the nanoparticles using single photon emission computerized tomography (SPECT). The resulting engineered nanosystem was tested in a xenograph mouse model of human pancreatic adenocarcinoma. Imaging results demonstrate that accumulation of targeted SCPNs in the tumor is higher than that observed for nontargeted nanoparticles due to improved retention in this tissue. ¸ 2016 American Chemical Society

Functional Single-Chain Polymer Nanoparticles : Targeting and Imaging Pancreatic Tumors in Vivo

The development of tools for the early diagnosis of pancreatic adenocarcinoma is an urgent need in order to increase treatment success rate and reduce patient mortality. Here, we present a modular nanosystem platform integrating soft nanoparticles with a targeting peptide and an active imaging agent for diagnostics. Biocompatible single-chain polymer nanoparticles (SCPNs) based on poly(methacrylic acid) were prepared and functionalized with the somatostatin analogue PTR86 as the targeting moiety, since somatostatin receptors are overexpressed in pancreatic cancer. The gamma emitter 67Ga was incorporated by chelation and allowed in vivo investigation of the pharmacokinetic properties of the nanoparticles using single photon emission computerized tomography (SPECT). The resulting engineered nanosystem was tested in a xenograph mouse model of human pancreatic adenocarcinoma. Imaging results demonstrate that accumulation of targeted SCPNs in the tumor is higher than that observed for nontargeted nanoparticles due to improved retention in this tissue